USANA Health Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 2, 2021
Revenue	912.67	854.5	921.01	998.6	1,186	1,135
Revenue Growth (YoY)	5.88%	-7.22%	-7.77%	-15.83%	4.57%	6.95%
Cost of Revenue	190	161.21	176.69	193.89	217.9	209.11
Gross Profit	722.67	693.29	744.32	804.71	968.57	925.53
Selling, General & Admin	680.85	626.97	651.25	697.1	798.37	749.04
Operating Expenses	680.85	626.97	651.25	697.1	798.37	749.04
Operating Income	41.82	66.32	93.07	107.61	170.19	176.49
Interest Expense	-0.85	-0.28	-0.26	-0.19	-0.06	-0.51
Interest & Investment Income	4.66	11.32	9.64	3.79	2.52	2.54
Other Non Operating Income (Expenses)	2.15	-1.01	0.01	-2.59	-2.01	-0.57
Pretax Income	47.78	76.35	102.45	108.62	170.64	177.95
Income Tax Expense	30.22	34.29	38.67	39.27	54.14	53.28
Earnings From Continuing Operations	17.56	42.06	63.79	69.35	116.51	124.66
Minority Interest in Earnings	-0.57	-0.03	-	-	-	-
Net Income	16.99	42.03	63.79	69.35	116.51	124.66
Net Income to Common	16.99	42.03	63.79	69.35	116.51	124.66
Net Income Growth	-68.74%	-34.11%	-8.02%	-40.48%	-6.54%	24.01%
Shares Outstanding (Basic)	19	19	19	19	20	21
Shares Outstanding (Diluted)	19	19	19	19	20	21
Shares Change (YoY)	-2.18%	-0.95%	0.18%	-5.08%	-4.29%	-6.84%
EPS (Basic)	0.91	2.20	3.31	3.60	5.78	5.89
EPS (Diluted)	0.90	2.19	3.30	3.59	5.73	5.86
EPS Growth	-68.25%	-33.64%	-8.08%	-37.35%	-2.22%	32.88%
Free Cash Flow	18.69	50.92	56.15	93.5	108.46	145.31
Free Cash Flow Per Share	0.99	2.66	2.90	4.84	5.33	6.84
Gross Margin	79.18%	81.13%	80.81%	80.58%	81.64%	81.57%
Operating Margin	4.58%	7.76%	10.11%	10.78%	14.34%	15.55%
Profit Margin	1.86%	4.92%	6.93%	6.94%	9.82%	10.99%
Free Cash Flow Margin	2.05%	5.96%	6.10%	9.36%	9.14%	12.81%
EBITDA	69.82	80.86	105.77	121.01	183.23	190.24
EBITDA Margin	7.65%	9.46%	11.48%	12.12%	15.44%	16.77%
D&A For EBITDA	28	14.54	12.7	13.39	13.04	13.75
EBIT	41.82	66.32	93.07	107.61	170.19	176.49
EBIT Margin	4.58%	7.76%	10.11%	10.78%	14.34%	15.55%
Effective Tax Rate	63.26%	44.91%	37.74%	36.15%	31.72%	29.94%
Advertising Expenses	-	4.97	4.76	5.05	12.4	9.85

Updated Oct 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q